New cancer clinical trial: Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer

Published on: July 25, 2018 at 12:00PM
Condition:   Pancreatic Cancer
Intervention:   Drug: Nivolumab + Cabiralizumab
Sponsor:   New York University School of Medicine
Not yet recruiting
https://ift.tt/2mL7WqF